Orenitram 90-Day Trial Program

Funded

About

The Orenitram 90-Day Trial Program offers patients the opportunity to trial up to a 90-day supply of Orenitram, a treatment for PAH (WHO Group 1). This program is designed for new patients who meet specific eligibility requirements and provides key benefits for those looking to start Orenitram therapy. Orenitram’s trial ensures patients can begin treatment seamlessly, with support accessible through designated contact points.

Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured, Uninsured

Enrollment Forms

Enrollment Form

Benefits

•1 maximum fills per year

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Must be 18 years of age or older

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Eligible patients new to therapy may be able to receive up to a 90day supply of Orenitram

•Trial Program is not valid for patients transitioning to Orenitram from Tyvaso or Remodulin

•HCP should fax enrollment form to 8003805294

•For assistance or additional information, call 8778648437

Enrollment Forms

Enrollment Form